Literature DB >> 58072

Further characterization of the Friend murine leukemia virus reverse transcriptase-RNase H complex.

K Moelling.   

Abstract

The purified reverse transcriptase-RNase H complex from Friend murine leukemia virus consists of a single polypeptide of 84,000 molecular weight, which after mild protease treatment in vitro or after intentional degradation during the purification procedure allows the generation of several additional polypeptides. Degradation destroys the RNA-dependent DNA polymerase activity with native RNA templates and reduces RNase H but does not affect response to synthetic template primers such as poly (rA)-Oligo (dT). The properties of the intact murine enzyme consisting of a single polypeptide of 84,000 molecular weight are compared to those of the avian alpha subunit and the avian alpha beta enzyme complex. The intact murine enzyme resembles the avian beta-containing enzyme complex and is different from alpha in the following respects: (i) it binds to native RNA templates; (ii) it transcribes native RNA templates into DNA, a reaction which can be inhibited by actinomycin D; (iii) RNase H activity behaves like a processive exonuclease; and (iv) analysis of the RNase H digestion products reveals oligonucleotides approximately four bases in length.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 58072      PMCID: PMC515566     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  DNA polymerase of murine sarcoma-leukemia virus: lack of detectable RNase H and low activity with viral RNA and natural DNA templates.

Authors:  L H Wang; P H Duesberg
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

2.  Purification of the DNA polymerase of avian myeloblastosis virus.

Authors:  D L Kacian; K F Watson; A Burny; S Spiegelman
Journal:  Biochim Biophys Acta       Date:  1971-09-24

3.  DNA polymerases of Rous sarcoma virus: delineation of two reactions with actinomycin.

Authors:  J P McDonnell; A C Garapin; W E Levinson; N Quintrell; L Fanshier; J M Bishop
Journal:  Nature       Date:  1970-10-31       Impact factor: 49.962

4.  Production of a potent complement-fixing murine leukemia virus-antiserum from the rabbit and its reactions with various types of tissue culture cells.

Authors:  W Schäfer; E Seifert
Journal:  Virology       Date:  1968-06       Impact factor: 3.616

5.  Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels.

Authors:  A L Shapiro; E Viñuela; J V Maizel
Journal:  Biochem Biophys Res Commun       Date:  1967-09-07       Impact factor: 3.575

6.  A comparative study of the avian reticuloendotheliosis virus: relationship to murine leukemia virus and viruses of the avian sarcoma-leukosis complex.

Authors:  K Moelling; H Gelderblom; G Pauli; R Friis
Journal:  Virology       Date:  1975-06       Impact factor: 3.616

7.  Reverse transcriptase and RNase H: present in a murine virus and in both subunits of an avian virus.

Authors:  K Moelling
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

8.  Purification, characterization, and comparison of the DNA polymerases from two primate RNA tumor viruses.

Authors:  J W Abrell; R C Gallo
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

9.  Studies on reverse transcriptase of RNA tumor viruses III. Properties of purified Moloney murine leukemia virus DNA polymerase and associated RNase H.

Authors:  I M Verma
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

10.  Purification and characterization of the DNA polymerase and RNase H activities in Moloney murine sarcoma-leukemia virus.

Authors:  G F Gerard; D P Grandgenett
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

View more
  19 in total

1.  Analysis of precursors to the envelope glycoproteins of avian RNA tumor viruses in chicken and quail cells.

Authors:  K Moelling; M Hayami
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

2.  Functional organization of the murine leukemia virus reverse transcriptase: characterization of a bacterially expressed AKR DNA polymerase deficient in RNase H activity.

Authors:  J G Levin; R J Crouch; K Post; S C Hu; D McKelvin; M Zweig; D L Court; B I Gerwin
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

3.  Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities.

Authors:  N Tanese; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

4.  Linker insertion mutagenesis of the human immunodeficiency virus reverse transcriptase expressed in bacteria: definition of the minimal polymerase domain.

Authors:  V R Prasad; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  Reverse transcriptase-associated RNase H activity. II. Inhibition by natural and synthetic RNA.

Authors:  S L Marcus; S W Smith; M J Modak
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

6.  Elongation of DNA complementary to the 5' end of the avian sarcoma virus genome by the virion-associated RNA-dependent DNA polymerase.

Authors:  U Novak; R Friedrich; K Moelling
Journal:  J Virol       Date:  1979-05       Impact factor: 5.103

7.  Radioimmunoassay for mammalian type C viral reverse transcriptase.

Authors:  J M Krakower; M Barbacid; S A Aaronson
Journal:  J Virol       Date:  1977-05       Impact factor: 5.103

8.  Immunological characterization of the RNA-dependent DNA polymerase from reticuloendotheliosis virus.

Authors:  K Moelling
Journal:  Med Microbiol Immunol       Date:  1977       Impact factor: 3.402

9.  Effect of polymerase mutations on packaging of primer tRNAPro during murine leukemia virus assembly.

Authors:  J G Levin; J G Seidman
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

10.  Mechanism of action of Moloney murine leukemia virus RNase H III.

Authors:  G F Gerard
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.